Patents Examined by Robert J Yamasaki
-
Patent number: 11970691Abstract: Provided is an immobilized thermostable trehalose synthase including an amino acid sequence of a trehalose synthase domain and an amino acid sequence of a cellulose binding domain. Also provided is a method for converting maltose into trehalose or for converting sucrose into trehalulose by using the immobilized thermostable trehalose synthase.Type: GrantFiled: March 19, 2021Date of Patent: April 30, 2024Assignee: National Taiwan Normal UniversityInventor: Guan-Chiun Lee
-
Patent number: 11970685Abstract: Methods and systems for preparing clonal cell populations are described. In some instances the disclosed methods comprise: a) identifying and selecting a cell based on its position on a surface or in a container, where the selection is not based on whether the cell comprises an exogenous label or an expressed reporter; b) photoablating all non-selected cells on the surface or in the container; and c) growing a clonal population of the selected cell.Type: GrantFiled: May 4, 2021Date of Patent: April 30, 2024Assignee: Synthego CorporationInventors: Reed Kelso, Travis Maures
-
Patent number: 11971337Abstract: Disclosed are compositions and methods for inactivating one or more enzymes in a biological sample.Type: GrantFiled: October 4, 2021Date of Patent: April 30, 2024Assignee: VENTANA MEDICAL SYSTEMS, INC.Inventors: James Grille, Brian D. Kelly, Jerome Kosmeder, II, Eric May, Noemi Sebastiao, Pamela Wirth
-
Patent number: 11965195Abstract: An enzyme-mediated method for the production of 3a-ethyl-6,6,9a-trimethyldodecahydronaphtho[2,1-b]furan, the products of said method, and uses of said products.Type: GrantFiled: December 3, 2020Date of Patent: April 23, 2024Assignee: GIVAUDAN SAInventors: Eric Eichhorn, Felix Flachsmann
-
Patent number: 11959122Abstract: A method for assessing microbial drug resistance multi-level risks of antibiotic residues in water environments, belonging to the technical field of water environment assessment, comprises the following steps: S1, environment monitoring; S2, preliminary screening of antibiotics: S2-1, determination of n-octanol/water partition coefficient, and S2-2, determination of antibiotic environment concentration; S3, assessment of microbial drug resistance; and S4, high-level assessment. The assessment method of the present disclosure conducts a step-by-step assessment of target antibiotics or target antibiotic derivatives in water environment with risks.Type: GrantFiled: May 27, 2023Date of Patent: April 16, 2024Assignees: NANJING INSTITUTE OF ENVIRONMENTAL SCIENCES, MEE, NANJING UNIVERSITYInventors: Xinyan Guo, Na Wang, Qingbin Yuan, Ni Ni, Xiaohui Zhang, Mali Shi, Jingbiao Li
-
Patent number: 11946088Abstract: The disclosure discloses a method for processing oil crops with rhodotorula, and belongs to the technical field of fermentation. The method includes the step of inoculating the rhodotorula (such as Rhodotorula mucilaginosa, Sporidiobolus salmonicolor and Rhodotorula glutinis) that can produce carotenoid into a fermentation medium that contains oil-rich oil crops for solid state fermentation to obtain oil and oil crop meal rich in carotenoid. The carotenoid as a fermentative metabolite of the rhodotorula has bioactivities of resisting oxidation, preventing vascular sclerosis, enhancing immunity and preventing cancers. Contents of carotenoid in the oil and oil crop meal acquired by the method can be up to 9.071 ?g/g and 8.062 ?g/g correspondingly.Type: GrantFiled: June 18, 2021Date of Patent: April 2, 2024Assignee: JIANGNAN UNIVERSITYInventors: Yuanfa Liu, Zhongyang Ding, Yunzhi Jiang, Liting Zhao, Mengmeng Xu, Qi Zhang, Zhenghua Gu, Guiyang Shi
-
Patent number: 11946093Abstract: A method and modified fermentation intermediate are disclosed for the production of polyunsaturated fatty acid (PUFA). The method comprises heat sterilizing a fermentation medium comprising dextrose to produce a heat sterilized fermentation medium, wherein the heat sterilizing converts at least a portion of the dextrose to DP2+ sugars. The method comprises combining the heat sterilized fermentation medium with an enzyme capable of converting DP2+ sugars to dextrose, thereby producing a modified heat sterilized fermentation medium comprising more dextrose and less DP+ 2 sugars than without combining the medium with the enzyme. The modified heat sterilized fermentation intermediate may be placed in contact with a microorganism to produce PUFA, wherein the microorganism is capable of utilizing dextrose to produce PUFA.Type: GrantFiled: October 16, 2019Date of Patent: April 2, 2024Assignee: ARCHER-DANIELS-MIDLAND COMPANYInventor: Jill M. Morriss
-
Patent number: 11938165Abstract: Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.Type: GrantFiled: August 18, 2021Date of Patent: March 26, 2024Assignees: Omrix Biopharmaceuticals Ltd., Ethicon, Inc.Inventors: Tamar Auerbach-Nevo, Ashley Deanglis, Israel Nur
-
Patent number: 11939615Abstract: The present invention discloses a production method of enzymatic reaction using adenosine instead of ATP. The method comprises the following steps: (1) adding ATP regeneration enzyme, AK enzyme and adenosine in proportion to carry out an enzymatic reaction in an enzymatic reaction system; (2) separating the ATP regeneration enzyme and AK enzyme by either directly separating ATP regeneration enzyme and AK enzyme immobilized in a reaction tank or separating free ATP regeneration enzyme and AK enzyme by an ultrafiltration membrane in a filter; and (3) separating and purifying the filtrate of step (2) to obtain a product. The disclosed method provides: greatly reduced industrial production costs; faster reaction rate; stable enzyme recovery system that is energy efficient and environmentally friendly; and capability of reusing the byproducts or collecting them for the production of ATP.Type: GrantFiled: June 6, 2018Date of Patent: March 26, 2024Assignee: ANHUI GSH BIO-TECH CO., LTD.Inventors: Shanshan Liu, Hui Liu, Wenwen Zhou, Yongfa Qin
-
Patent number: 11932891Abstract: The subject invention provides microbe-based products and efficient methods of producing them. In specific embodiments, methods are provided for enhanced production of microbial biosurfactants, the methods comprising co-cultivating Myxococcus xanthus and Bacillusamyloliquefaciens. In preferred embodiments, co-cultivation is carried out continuously for an indefinite period of time. Microbe-based products produced according to the subject methods are also provided, as well as their uses in, for example, agriculture, oil and gas recovery, and health care.Type: GrantFiled: March 31, 2020Date of Patent: March 19, 2024Assignee: LOCUS SOLUTIONS IPCO, LLCInventors: Sean Farmer, Ken Alibek, Yajie Chen
-
Patent number: 11920176Abstract: Disclosed is a method for producing biogas from a waste liquid/residue after diosgenin extraction by aluminum chloride. Specifically, in a fermentation vessel, an anaerobic sludge and a waste residue from diosgenin extraction by aluminum chloride are added at a volatile solids ratio of (1-3):(1-2), or a seeding sludge and a diosgenin waste liquid are added with an organic loading having a VS:COD ratio of (1-2):(1-2); and then the above components are fermented at 35-37° C. for 5-25 d such that biogas is produced. According to the method of the present invention, the maximum cumulative biogas production rates are 255.4 mL/g VS for waste residue and 326.9 mL/g COD for waste liquid, and throughout the fermentation period, ammoniacal nitrogen values are below 1500 mg/L and pH variation is within the normal range, and the COD removal rate for the fermentation broth is 91.11%.Type: GrantFiled: November 27, 2020Date of Patent: March 5, 2024Assignee: SOUTH CHINA AGRICULTURAL UNIVERSITYInventors: Jun Xie, Guican Bi, Hongdan Zhang
-
Patent number: 11905542Abstract: The present invention is related to a novel enzymatic process for production of retinyl esters, such as in particular retinyl long chain esters, via conversion of retinol, which process includes the use of enzymes having acyltransferase activity. Said process might be used for biotechnological production of vitamin A.Type: GrantFiled: September 25, 2018Date of Patent: February 20, 2024Assignee: DSM IP ASSETS B.V.Inventors: Nathalie Balch, Paul Blomquist, Reed Doten, Peter Houston, Ethan Lam, Jenna McMahon, Joshua Trueheart, Celine Viarouge
-
Patent number: 11905548Abstract: An immobilized enzymatic reactor can include a wall defining a chamber having an inlet and an outlet; a solid stationary phase covalently linked to an enzyme and disposed within the chamber; and a pressure modulator in a fluid communication with the chamber and adapted to support continuous flow of a liquid sample comprising a polymer analyte through the inlet, over the solid stationary phase, and out of the outlet under a pressure between about 2,500 and 35,000 psi. In one example, the solid stationary phase includes inorganic/organic hybrid particles in an ultra performance liquid chromatography system, the enzyme is a protease, and the polymer analyte is a polypeptide. The immobilized enzymatic reactor can prepare an analyte for applications such as for hydrogen deuterium exchange mass spectrometry.Type: GrantFiled: August 4, 2022Date of Patent: February 20, 2024Assignee: Waters Technologies CorporationInventors: Joomi Ahn, Moon Chul Jung, Kevin D. Wyndham
-
Patent number: 11897831Abstract: Disclosed are a pregabalin artificial hapten, artificial antigen and preparation method therefor and application thereof. The structure of the pregabalin artificial hapten is shown as formula (I) and structure of the pregabalin artificial antigen is shown as formula (II). The application is in the preparation for anti-pregabalin antibodies with the pregabalin artificial antigen. The pregabalin artificial hapten retains the characteristic structure of pregabalin to the greatest extent, and has an active group that can be coupled with a carrier protein, and can be used as an antigenic determinant; the pregabalin artificial antigen obtained by further preparation can immune to obtain anti-pregabalin antibodies with high affinity, high sensitivity and strong specificity. The titer of the immune serum obtained by immunizing New Zealand white rabbits is as high as 1:90000, which can be used for rapid and accurate immunoassay of pregabalin.Type: GrantFiled: August 10, 2021Date of Patent: February 13, 2024Assignee: HANGZHOU TONGZHOU BIOTECHNOLOGY CO., LTD.Inventors: Yueshui Shao, Zhen Wang
-
Patent number: 11898139Abstract: Provided herein is a culturing method for bacteria of the genus Rhizobium whereby a low viscosity can be maintained in a culture solution during the culturing of and at the end of culturing of said bacteria, and that enables easy and efficient post-procedures, including concentration and separation of viable bacteria, among others. This is achieved by growing Rhizobium bacteria by liquid culture using a medium containing a disaccharide (for example, maltose, trehalose, lactose, sucrose) accounting for at least 25 mass % of the carbon source in the medium while maintaining a pH of 5.0 to 7.0 in the culture solution throughout the course of the culture, namely from the beginning of the culturing to the end of the culturing of said bacteria.Type: GrantFiled: October 23, 2018Date of Patent: February 13, 2024Assignees: Kumiai Chemical Industry Co., Ltd., K.I Chemical Industry Co., Ltd., Okayama Prefectural GovernmentInventors: Toshinobu Yamazaki, Shingo Hattori, Tatsuya Horiuchi
-
Patent number: 11899009Abstract: A method for adjusting the maturation state of mammalian sperm for use in assisted reproductive technologies (ART) is disclosed. A mammalian ejaculate is provided and incubated under controlled conditions. Aliquots of the ejaculate are assayed during incubation period at intervals to determine maturation state and changes in the maturation state by observing the percent positive cells in the aliquot. The assays are repeated with successive aliquots at intervals during incubation to observe real time changes in the maturation state. The ejaculate remaining is processed for the desired ART after the percentage of positive cells in the latest aliquot being assayed begins to decline.Type: GrantFiled: November 21, 2019Date of Patent: February 13, 2024Assignee: AREX LIFE SCIENCES, LLCInventor: Barb A. Cohen
-
Patent number: 11898189Abstract: A microalgal strain of the species Nannochloropsis gaditana is characterized by a mutation of an enzyme involved in the biosynthesis of chlorophyll that changes the physiology thereof with respect to the wild-type strain of the same species. In particular, with the mutation, microalgae are formed which, with respect to the wild-type strain of the same species, have a lower chlorophyll content and a reduced capacity to absorb visible radiation (light). Further, a process for the production of lipids through the cultivation of the mutated Nannochloropsis gaditana strain and the lipids obtained can be used as synthesis intermediates, particularly in the so-called “green-chemistry” sector or in the production of biofuels.Type: GrantFiled: December 5, 2019Date of Patent: February 13, 2024Assignee: ENI S.P.A.Inventors: Roberta Miglio, Tomas Morosinotto, Alessandra Bellan
-
Patent number: 11891642Abstract: A method for the use of a cytochrome P450 enzyme comprising any of SEQ ID NO: 1-118, or mutants thereof or a variant enzyme having at least 70% identity thereto and having CYP450 activity, for the hydroxylation and or dealkylation of an organic compound.Type: GrantFiled: November 26, 2019Date of Patent: February 6, 2024Assignee: HYPHA DISCOVERY LIMITEDInventors: Jonathan Charles Paul Steele, Antonio De Riso, Francesco Falcioni, Richard Kerry Phipps, Stephen Keith Wrigley, Emily Jade Hopkins, Aksana Rimu Khan, Tetsuo Kokubun, Kinga Linda Nytko, Vincent Poon, Sebastian Schulz, John Maxim Ward, Mariacristina Bawn
-
Patent number: 11892410Abstract: The present invention relates to a method for preparing a solid-state photonic crystal IPN composite functionalized with an enzyme, a photonic crystal IPN composite prepared by the method, and a biosensor using the photonic crystal IPN composite. The method of the present invention includes (1) mixing a nonreactive chiral dopant with a reactive nematic mesogen, curing the mixture, and removing the chiral dopant while maintaining a helical structure, to form a solid-state helical photonic crystal structure, (2) infiltrating a PAA hydrogel into the internal space of the photonic crystal structure, followed by curing to form an IPN-structured composite, and (3) immobilizing an enzyme in the IPN-structured composite. The PAA hydrogel is infiltrated into the solid-state helical photonic crystal structure and the enzyme is immobilized such that a pH change caused by the enzymatic reaction induces shrinkage and expansion of the PAA hydrogel, leading to a color change.Type: GrantFiled: February 20, 2019Date of Patent: February 6, 2024Assignee: Kyungpook National University Industry-Academic Cooperation FoundationInventors: Soo Young Park, Kyung Gyu Noh
-
Patent number: 11891640Abstract: The present disclosure relates to terpene synthases capable of producing terpenoids. In one instance, a transformed organism can include terpene synthases or vectors encoding such synthases. One method of employing such synthases and organisms includes protecting an algal culture, in which the produced terpenoid can act as a biocide.Type: GrantFiled: January 20, 2021Date of Patent: February 6, 2024Assignee: National Technology & Engineering Solutions of Sandia, LLCInventors: Ryan Wesley Davis, Tyler Phillips Eckles, Nataly Lyn Beck, Oliver Kilian